Top 10 CRO Solution Providers 2024

The field of contract research organizations plays a pivotal role in driving innovation and accelerating the pace of drug discovery and development. As pharmaceutical and biotechnology companies strive to bring life-saving therapies to market faster and more efficiently, the demand for CRO services continues to soar. Against the backdrop of a rapidly evolving healthcare landscape, characterized by technological advancements, regulatory changes, and shifting patient demographics, CROs are at the forefront of revolutionizing the way clinical trials are conducted.

This special edition features some of the latest industry trends shaping the future of CROs, including the rising importance of decentralized clinical trials (DCTs), the integration of artificial intelligence (AI) and machine learning in clinical research, and the growing emphasis on patient-centricity. As the healthcare industry continues to embrace digital transformation and adopt innovative approaches to drug development, CROs are leveraging these trends to drive efficiency, improve patient outcomes, and bring therapies to market more quickly.

Explore the stories of the Top 10 CRO Solution Providers 2024 who are driving innovation, fostering collaboration, and making a positive impact on the future of healthcare. From groundbreaking technologies to visionary leadership, the companies in this listing exemplify excellence in the field of clinical research and stand as beacons of progress in an ever-evolving industry.

Altasciences

Management:

Chris Perkin

Designation:

CEO

Headquarters:

Laval, Canada

Website:

altasciences.com

Altasciences is a unique player in the contract research organization (CRO) and contract development and manufacturing organization (CDMO) space by offering a holistic approach to early-phase drug development. Unlike traditional CROs that may focus on isolated steps in the process, Altasciences offers a unified continuum, streamlining the journey from lead candidate selection to clinical proof of concept, and beyond.

Dr. Vince Clinical Research

Management:

Dr. Bradley D. Vince

Designation:

CEO

Headquarters:

Overland Park, KS

Website:

drvince.com

Dr. Vince Clinical Research (DVCR), a leading full-service contract research organization (CRO), specializes in early phase trials across diverse therapeutic areas. Their comprehensive CRO services encompass project management, data management, biostatistics, monitoring, PK/PD analysis, and medical writing. With a state-of-the-art clinical pharmacology unit boasting over 90 beds and luxurious amenities, DVCR prioritizes participant recruitment and retention. Leveraging technology and experienced leadership, they deliver Smarter Faster Data® to biopharmaceutical clients.

Ergomed CRO

Management:

Dr Miroslav Reljanović

Designation:

Executive Chairman

Headquarters:

Surrey, England

Website:

ergomedcro.com

Established in 1997, Ergomed has emerged as a premier global provider of top-tier services to the biopharmaceutical sector. Covering every facet of clinical trials, post-approval pharmacovigilance, and medical information, Ergomed boasts a rapidly expanding suite of specialist pharmacovigilance solutions under the esteemed PrimeVigilance brand. Their Ergomed Clinical Research arm offers comprehensive Phase I-IV clinical development and trial management services, particularly renowned for expertise in rare diseases and oncology.

FGK Clinical Research

Management:

Martin Krauss

Designation:

MD

Headquarters:

Bayern, Germany

Website:

fgk-cro.com

FGK Clinical Research GmbH stands as a comprehensive contract research organization, catering to pharmaceutical, biotechnology, and medical device firms. Their full-service approach encompasses a wide array of clinical development and consulting services. With a commitment to excellence, they provide tailored solutions to drive innovation and facilitate the advancement of medical products, ensuring optimal outcomes for their clients and the patients they serve.

PSI CRO

Management:

Nick Sinackevich

Designation:

President

Headquarters:

Durham, NC

Website:

psi-cro.com

PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas. PSI is known in the industry as a CRO focused on ‘on-time project delivery’. This is achieved through investing substantial effort and MD resources into performing quality feasibility assessments that provide an accurate predictor of study timelines.

Quanticate

Management:

David Underwood

Designation:

Chairman & CEO

Headquarters:

Hertfordshire, England

Website:

quanticate.com

Quanticate is a leading global data focused clinical research organisation (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Quanticate can offer study level support, functional service provision (FSP), strategic full data-services solutions or technical consultancy to meet the needs of pharmaceutical, biotechnology and device companies across the globe.

SanaClis s.r.o

Management:

Alexander Fetkovsky

Designation:

CEO

Headquarters:

Bratislava, Slovakia

Website:

sanaclis.com

Founded in 2000, SanaClis is a full-service Global CRO and one of the very few service providers with an extensive array of in-house clinical supply chain, logistics and sourcing skills, offering a comprehensive range of end-to-end solutions for clinical trials worldwide throughout the entire life cycle of the study. Adapting to the needs of the sponsor, SanaClis is able to work both as a full and functional service provider.

SCIRENT

Management:

Hans-Dirk Duengen

Designation:

Founder & CEO

Headquarters:

Berlin, Germany

Website:

scirent.com

SCIRENT is a leading contract research organization specializing in cardiovascular trials. Their full-service approach encompasses all phases of clinical trial management for pharmaceutical, biotech, and medical device companies. With a focus on lean management, dedicated staff, and a specialized site network, they facilitate the development of innovative medical treatments. Their expertise ranges from early protocol development to regulatory consulting and publication of study results, ensuring comprehensive support throughout.

Syneos Health

Management:

Alistair Macdonald

Designation:

CEO

Headquarters:

Morrisville, NC

Website:

syneoshealth.com

Syneos Health®, a premier fully integrated biopharmaceutical solutions organization, is dedicated to expediting customer success by translating clinical, medical affairs, and commercial insights into tangible outcomes. With a global presence across 110 countries, their talented team leverages deep understanding of patient and physician behaviors, alongside market dynamics, to accelerate the delivery of vital therapies to patients.

Tranquil Clinical Research

Management:

Karim Mohammed

Designation:

President & CEO

Headquarters:

Webster, TX

Website:

tranquilclinicalresearch.com

Tranquil Clinical Research stands as a beacon of ethical practice and patient-centric care in the realm of clinical trials. With an unwavering commitment to excellence, every stage of their operations is meticulously crafted to uphold the highest standards of quality and integrity. Their business model is not just about conducting trials but about championing the well-being and trust of the patients they serve, setting a commendable standard in the industry.